WilmerHale Represents General Catalyst Partners in its Series E Preferred Stock Investment in Olive

WilmerHale Represents General Catalyst Partners in its Series E Preferred Stock Investment in Olive

Client News

Related Solutions

Helping clients launch their businesses and transform their innovative ideas into successful companies.

WilmerHale represented General Catalyst Partners in its Series E preferred stock investment in Olive, a company creating AI workforce for healthcare. On March 31, 2020, Olive announced the closing of its $51 million funding round led by General Catalyst, which will enable Olive to accelerate its growth and further its mission of automating healthcare’s administrative processes so hospital employees can focus on delivering high-quality, cost-effective care. Drive Capital, Oak HC/FT, Ascension Ventures and several others also participated in the financing.

The WilmerHale team representing General Catalyst consisted of Jason Kropp, Mark Nylen, and Korey Cowan, with assistance from Kirk Nahra, Kim Wethly, Ciara Baker, Ariel Soiffer and Ali Jessani.

Read the press release for more information.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel